Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
Clinical trial NCT01873833 · TERMINATED
Trial details
- NCT number
- NCT01873833
- Sponsor
- University of Southern California
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-29
- Primary completion
- 2021-03-02
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.